Now Entering Russ's World
Jeff Aronin has been the chief executive officer of Paragon Pharmaceuticals, since January 2010. Jeff has an M.B.A from the DePaul University and a BSc. from Northern Illinois University. Jeff founded Paragon Pharmaceuticals in December 2009. Aronin is also the founder of Matter. He served as the chief executive officer, president and the chief operating officer of Lundbeck until December 2009. Mr. Aronin also served as president of the Ovation Pharmaceuticals. Aronin has been Director at Discover financial services since January 1, 2007.
Jeff is a board member of the Chicagoland Entrepreneurial Center. He is a Henry Crown Fellow at the Aspen Institute. Jeff received Ernst and Young`s Entrepreneur of the Year Award, and he is on the Entrepreneur Hall of Fame. He has many years’ experience in pharmaceuticals and finance. He is recognized as an industry-leading life sciences entrepreneur. He is a business leader, investor in life sciences, philanthropist and the entrepreneur.
Paragon Biosciences is an incubator and investor that builds and leads to the growth of the biotechnology companies. The mission of Paragon Biosciences is to help people to live longer and healthier lives as directed by Jeff Aronin. Paragon Biosciences successful strategy is based on three steps. These steps include the following:
Paragon`s target is to reduce the number of the diseases that do not have treatment. They are working tirelessly to find solutions so that patients can live longer and better lives. Paragon Bioscience was developed with the aim of building innovative companies that bring essential medicines to patients. Paragons companies conduct all clinical test and developments and work together with medical professionals with the intention of providing what is required by the patients. Jeff Aronin is the brainchild behind the success of Paragon (Wikidot).